论文部分内容阅读
支气管哮喘持续状态、严重的喘息型支气管炎及肺心病并发冠心病的心源性哮喘,是临床治疗上比较棘手的病症.近年来,我们采用酚妥拉明治疗了32例,效果良好.报告如下. 临床资料 32例病人中,男18例、女14例。其中50岁以上24例,50岁以下的8例.年龄最小的31岁,年龄最大的88岁。其中,支气管哮喘持续状态2例,喘息型支气管炎25例,肺心病并发冠心病的心源性哮喘5例.这些均系经补液、吸氧、静注氨茶碱、使用激素、654-2、异丙嗪等治疗无效的病人,于是我们改用了酚妥拉明治疗。
Bronchial asthma persistence, severe asthmatic bronchitis and pulmonary heart disease complicated with coronary heart disease of the heart-derived asthma, is a more difficult clinical treatment of the disease.In recent years, we treated with phentolamine in 32 cases, the effect is good.Report As follows. Clinical data 32 patients, 18 males and 14 females. Among them, 24 cases were over 50 years old and 8 cases were below 50 years old.The youngest 31 years old, the oldest 88 years old. Among them, bronchial asthma persistence in 2 cases, wheezing bronchitis in 25 cases, pulmonary heart disease complicated with coronary heart disease in 5 cases of cardiogenic asthma, these are by rehydration, oxygen, intravenous aminophylline, the use of hormones, 654-2 , Promethazine and other invalid treatment of patients, so we switched to phentolamine treatment.